Unibest

Pharmaceutical intermediates

Fostamatinib disodium hexahydrate Intermediates

1 pharmaceutical intermediate for Fostamatinib disodium hexahydrate. Indication: Idiopathic thrombocytopenic purpura; Thrombocytopenia.

Submit a ProjectAll intermediates

About Fostamatinib disodium hexahydrate

Originator
Rigel Pharmaceuticals Inc
Indication
Idiopathic thrombocytopenic purpura; Thrombocytopenia
Approved Date
04/17/2018
DS/DP
01/19/2026

Available intermediates

1 intermediate currently listed for Fostamatinib disodium hexahydrate. Request specifications, documentation or a quotation for any item below.

Fostamatinib disodium hexahydrate intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
6-Amino-2,2-dimethyl-2H-pyrido[3,2-B][1,4]oxazin-3(4H)-one1002726-62-6//

Other programs under F

FebuxostatFexuprazan HClFezolinetantFilgotinib MaleateFinerenoneFluralanerFruquintinibFutibatinib

Building toward Fostamatinib disodium hexahydrate?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →